arrow_back Back to App

Tardive Dyskinesia Awareness Week: Boosting Knowledge of the Disorder

The U.S. Senate designated the week of May 2-8, 2021, as "Tardive Dyskinesia Awareness Week." This aims to increase public knowledge about this movement disorder, which can affect individuals taking certain medications, and encourages citizens to become better informed. Increased awareness can lead to earlier recognition and better management of the condition, benefiting patients and caregivers.
Key points
Designation of Tardive Dyskinesia Awareness Week for public education.
Highlighting that tardive dyskinesia is a movement disorder that can occur after treatment with certain medications, even after discontinuation.
Encouraging citizens to learn about the symptoms and risks of tardive dyskinesia, potentially leading to earlier diagnosis and improved care.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_184
Sponsor: Sen. Murphy, Christopher [D-CT]
Process start date: 2021-04-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating the week of May 2, 2021, through May 8, 2021, as "Tardive Dyskinesia Awareness Week".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_184.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-04-28.

What are the main provisions?

Key points include:

  • Designation of Tardive Dyskinesia Awareness Week for public education.
  • Highlighting that tardive dyskinesia is a movement disorder that can occur after treatment with certain medications, even after discontinuation.
  • Encouraging citizens to learn about the symptoms and risks of tardive dyskinesia, potentially leading to earlier diagnosis and improved care.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Murphy, Christopher [D-CT].

What is the latest detailed status?

The latest detailed status is: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (text: 4/28/2021 CR S2297-2298)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health